How Insilico Medicine Is Using AI To Reinvent Drug Discovery

Insilico Medicine has shown that generative AI can dramatically accelerate drug discovery, but its bigger challenge is ...
Nasdaq

Forget The Chips: Oracle Wins Phase 2 of AI

Investors watched Oracle Corporation (NYSE: ORCL) surge to a closing price of $198.38 on Dec. 22, marking a gain of over 3% on heavy trading volume. While the broader technology sector has spent the ...
The Manila Times

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

Dasher Neuroscience Holdings Inc. (TPEx: 7829) ('Dasher Neuroscience'), an AI-driven biopharmaceutical company focused on central nervous system (CNS) drug discovery and development, today announced ...

AI’s Next Phase Will Be Measured In Workflow ROI, Not Tokens

For AI to move from “useful tool” to “economic infrastructure,” it has to be tied to a measurable unit of work.